1 minute read
COMMITS ONCE AGAIN TO SUPPORT CANCER RESEARCH
from Issue 27
Multiple Myeloma Fund.”
After 12 years of battling cancer, on August 23 2013, Corman sadly passed away. It is to honour his legacy of generosity that R. J. Corman Railroad Group is committed to supporting cancer research every year.
Advertisement
As a way of celebrating 50 years of history, and through the generous donations of employees, a gift in honour of the company's friends and customers this past Christmas, and a company donation, R. J. Corman Railroad Group is honoured to donate a combined contribution of $50,000 to the “Richard J. Corman Multiple Myeloma Fund.”
Dr. Richardson (now Clinical Program Leader and
Director of Clinical Research of the Jerome Lipper Multiple Myeloma Centre and R. J. Corman, Professor of Medicine at Harvard Medical School) and Dr. Constantine S. Mitsiades (Associate Professor in Medicine at Harvard Medical School) joined R. J. Corman Railroad Group President and CEO Ed Quinn on a virtual conference call with the company for an update on the advances in their progressive work on this cancer research.
R. J. Corman Railroad Group is incredibly grateful for this partnership and the opportunity to allow it to support the battle to cure this terrible disease, says the group.
